Gastroesophageal reflux disease (GERD) affects ≈ 13 % of adults in the United States and ≈ 20 % of adults in Western Europe, imposing an annual economic burden of ≈ $12 billion in direct health‑care costs. The pathophysiology centers on transient lower esophageal sphincter relaxations (TLESRs) a… 📌 Key Points 📌 Overview and Epidemiology 📌 Pathophysiology 📌 Clinical Presentation ⏱ 8 min read 📖 Full article + sources: 🔗 https://medmind.pro/articles/famotidine-in-the-management-of-gastroesophageal-reflux-disease-pharmacology-clinical-use- 📚 Free medical platform: medmind.pro #MedicalEducation #Medicine #MedMindAI #USMLE #MedStudent #Pharmacology
💊 Famotidine in the Management of Gastroesophageal Reflux Disease: Pharmacology, Clinical Use, and Outcomes
Gastroesophageal reflux disease (GERD) affects ≈ 13 % of adults in the United States and ≈ 20 % of adults in Western Europe, imposing an annual economic burden of ≈ $12 billion in direct health‑care costs. The pathophysiology centers on transient lower esophageal sphincter relaxations (TLESRs) a…
📌 Key Points
📌 Overview and Epidemiology
📌 Pathophysiology
📌 Clinical Presentation
⏱ 8 min read
📖 Full article + sources:
📚 Free medical platform: medmind.pro
#MedicalEducation #Medicine #MedMindAI #USMLE #MedStudent
#Pharmacology
